Primary Navigation for the CDC Website
CDC en Español

Search:  

SMALLPOX SUPPLEMENTAL FACT SHEET

Investigational Vaccinia Immune Globulin (VIG) Information

Languages

The smallpox vaccine is made from a live virus related to smallpox called vaccinia (not smallpox virus). The vaccine stimulates the immune system to react against the vaccinia virus, and develop immunity to it. Immunity to vaccinia also provides immunity to smallpox. For most people, live virus vaccines are safe and effective. Some people, however, are at greater risk for serious side effects from the smallpox vaccine. Vaccinia Immune Globulin (VIG) may help people who have certain serious reactions to the smallpox vaccine. VIG is an investigational new drug (IND) made from plasma from the blood of people who have immunity to smallpox. If you develop a serious reaction to the smallpox vaccine, you may be offered VIG.

VIG Information

How is VIG administered?

VIG is given by a needle in the muscle in the arm (VIG-IM), or by a needle in a vein in the arm (VIG-IV). The type of VIG (IM vs. IV) given will depend on which is available.

Side Effects


CDC public response hotline:
800-CDC-INFO
888-232-6348 (TTY)

Page last reviewed February 7, 2007
Page last modified January 16, 2003

Content Source:


Navigation for the CDC Emergency Preparedness and Response Website

• Home


Additional Navigation for the EPR Website


Additional Navigation for the CDC Website

“Safer Healthier People”
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
CDC Contact Center: 800-CDC-INFO (800-232-4636) • 888-232-6348 (TTY) • cdcinfo@cdc.gov
Director's Emergency Operations Center (DEOC): 770-488-7100